Cargando…
Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization
Individuals with the highest risk for adverse outcomes of COVID-19 should be prioritized by the vaccine allocation policies. We have conducted a literature review of published studies, which comprehend congenital heart disease (CHD) and COVID-19, in order to present the overall evidences of both exp...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206548/ https://www.ncbi.nlm.nih.gov/pubmed/35360449 http://dx.doi.org/10.1016/j.ijcchd.2021.100186 |
_version_ | 1783708650188046336 |
---|---|
author | Sabatino, Jolanda Di Salvo, Giovanni Calcaterra, Giuseppe Bassareo, Pier Paolo Oreto, Lilia Cazzoli, Ilaria Calabrò, Maria Pia Guccione, Paolo Gatzoulis, Michael A. |
author_facet | Sabatino, Jolanda Di Salvo, Giovanni Calcaterra, Giuseppe Bassareo, Pier Paolo Oreto, Lilia Cazzoli, Ilaria Calabrò, Maria Pia Guccione, Paolo Gatzoulis, Michael A. |
author_sort | Sabatino, Jolanda |
collection | PubMed |
description | Individuals with the highest risk for adverse outcomes of COVID-19 should be prioritized by the vaccine allocation policies. We have conducted a literature review of published studies, which comprehend congenital heart disease (CHD) and COVID-19, in order to present the overall evidences of both exposure and clinical risk of patients with adult congenital heart disease (ACHD) and to propose a risk profile schema for those patients to be incorporated into vaccine distribution decisions. |
format | Online Article Text |
id | pubmed-8206548 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82065482021-06-16 Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization Sabatino, Jolanda Di Salvo, Giovanni Calcaterra, Giuseppe Bassareo, Pier Paolo Oreto, Lilia Cazzoli, Ilaria Calabrò, Maria Pia Guccione, Paolo Gatzoulis, Michael A. International Journal of Cardiology Congenital Heart Disease Article Individuals with the highest risk for adverse outcomes of COVID-19 should be prioritized by the vaccine allocation policies. We have conducted a literature review of published studies, which comprehend congenital heart disease (CHD) and COVID-19, in order to present the overall evidences of both exposure and clinical risk of patients with adult congenital heart disease (ACHD) and to propose a risk profile schema for those patients to be incorporated into vaccine distribution decisions. The Authors. Published by Elsevier B.V. 2021-08 2021-06-16 /pmc/articles/PMC8206548/ /pubmed/35360449 http://dx.doi.org/10.1016/j.ijcchd.2021.100186 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Sabatino, Jolanda Di Salvo, Giovanni Calcaterra, Giuseppe Bassareo, Pier Paolo Oreto, Lilia Cazzoli, Ilaria Calabrò, Maria Pia Guccione, Paolo Gatzoulis, Michael A. Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization |
title | Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization |
title_full | Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization |
title_fullStr | Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization |
title_full_unstemmed | Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization |
title_short | Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization |
title_sort | adult congenital heart disease: special considerations for covid-19 and vaccine allocation/prioritization |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206548/ https://www.ncbi.nlm.nih.gov/pubmed/35360449 http://dx.doi.org/10.1016/j.ijcchd.2021.100186 |
work_keys_str_mv | AT sabatinojolanda adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization AT disalvogiovanni adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization AT calcaterragiuseppe adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization AT bassareopierpaolo adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization AT oretolilia adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization AT cazzoliilaria adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization AT calabromariapia adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization AT guccionepaolo adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization AT gatzoulismichaela adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization AT adultcongenitalheartdiseasespecialconsiderationsforcovid19andvaccineallocationprioritization |